The 73rd China International Medical Equipment Fair (CMEF), which is regarded as the “feast of feasting†in the medical device industry , recently closed in Shanghai. The contrast between the “slot†and the “bright spot†of the exhibition was very clear. The transportation, accommodation, catering, service and supporting facilities were met by the collective “spits†of the audience, while the local medical equipment companies and international giants competed on the same stage and won numerous “ like". Leading local manufacturers such as Lian Ying Medical, Neusoft Medical and Mindray have started the “counterattack†to “GPSâ€, and the release of “Made in China 2025†has undoubtedly added infinite firepower to this “counterattackâ€. Localization process accelerates On May 19, with the approval of Premier Li Keqiang, the State Council officially issued "Made in China 2025" and upgraded the top ten industries such as biomedicine and high-performance medical devices into a "national strategy." Three decades, three steps, and among the world's manufacturing powers, this is the vision of "Made in China 2025" and the clarion call for tens of thousands of Chinese manufacturing companies. According to the newly released "Made in China 2025", the country will aim at a new generation of information technology, high-end equipment, new materials, biomedicine and other strategic priorities, guide the gathering of various resources in the society, and promote the rapid development of advantages and strategic industries. Among them, biomedicine and high-performance medical devices have become one of the core industries of the Chinese version of “Industry 4.0â€. Development of new products for chemical drugs, traditional Chinese medicines and biotechnology drugs for major diseases, including new mechanisms and new target chemical drugs, antibody drugs, antibody-conjugated drugs, new structural proteins and peptide drugs, new vaccines, and outstanding clinical advantages Chinese medicine and personalized treatment drugs. Analysts in the pharmaceutical industry pointed out: "Under the promotion of technological innovation, heavy new drugs and high-end medical device industry will usher in a new development space. The investment and declaration of listed companies on innovative drug research and development will gradually increase; the process of localization of medical devices It is also expected to accelerate." From "low" to "high" Regarding why "Made in China 2025" was introduced at this time, Miao Wei, Minister of Industry and Information Technology, said that in the process of coping with the international financial crisis, all countries realized that they could not give up support for the real economy at any time, and foreign countries have proposed " Re-industrialization, "Industry 4.0" and other plans. From the perspective of China's situation, economic development has entered a new normal, and the manufacturing industry has reached the stage of moving from the low end of the value chain to the middle and high end. Based on these circumstances, we must study what strategy should be used to deal with a new round of development, and how to achieve a stronger manufacturing industry. China's medical device industry is facing many challenges such as small scale of enterprises and weak research and development capabilities. According to statistics, about 90% of the medical device manufacturers that hold the "Medical Device Business Enterprise License" are low-tech SMEs with an annual income of less than 30 million yuan. The proliferation of imitations in the low-end market has accelerated the vicious competition at low prices and hindered the healthy development of China's medical device industry. The high-end market has long been occupied by imported brands, which has squeezed the profit margin of domestic medical device companies. If it is unable to climb from the low-end market to the high-end market, as China's demographic dividends ebb, the market expansion will slow down, low-cost and scale effects will no longer exist, and huge gross profit will also be shattered. "Made in China 2025" will significantly change the medical device manufacturing process, new material application, research and development level, and marketing network, and promote the transformation of Chinese medical device products from low-end to high-value-added high-end products. Shine Skin Pumpkin Seeds,Shine Skin Pumpkin Seeds Does,Shine Skin Pumpkin Seeds Extract,Shine Skin Pumpkin Seeds Edible Wuyuan county dafeng oil food co.,ltd , https://www.sundafengfoods.com